Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Research Report 2016

Publisher Name :
Date: 29-Dec-2016
No. of pages: 121
Inquire Before Buying

This report studies Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Global market, especially in North America, Europe, China, Japan, Taiwan and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Janssen Diagnostics

QIAGEN Hannover GmbH

Acousys Biodevices, Inc.

Advanced Cell Diagnostics, Inc.

ApoCell, Inc.

BioCEP Ltd.

Biocept, Inc.

Biofluidica

BioView Ltd.

Clearbridge Biomedics Pte Ltd.

Creatv MicroTech, Inc.

Cynvenio Biosystems

CytoTrack ApS

DeNovo Sciences Inc.

Epic Sciences

Fluidigm Corporation

Fluxion Biosciences

Miltenyi Biotec GmbH

SRI Biosystems

RareCells Diagnostics

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in these regions, from 2011 to 2021 (forecast), like

North America

China

Europe

Japan

Taiwan

India

Row

Split by Product Types and method to identify the cells, with production, revenue, price, market share and growth rate of each type, can be divided into

Enrichment Methods Based on Physical Properties

Immuno-Mediated Capture Methods

Optical Identification and Enumeration

Nucleic Acid-based CTC Detection Methods

Virus Vectors Fluorescence

Cell Adhesion Matrix

Rheology-based Methods

Split by applications, this report focuses on consumption, market share and growth rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in each application, can be divided into

Prognostic Tool for Survival

Non-Invasive Early Diagnosis of Cancer

Predictors of Disease Evolution and Metastatic Potential

Therapy Guidance and Monitoring/Predictor of Response to Therapy

Drug Development-Selection of Drug Targets

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Research Report 2016

Table of Contents
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Research Report 2016
1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Types
1.2.1 Global Production Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Types in 2015
1.2.2 Enrichment Methods Based on Physical Properties
1.2.3 Immuno-Mediated Capture Methods
1.2.4 Optical Identification and Enumeration
1.2.5 Nucleic Acid-based CTC Detection Methods
1.2.6 Virus Vectors Fluorescence
1.2.7 Cell Adhesion Matrix
1.2.8 Rheology-based Methods
1.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Applications
1.3.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Market Share by Applications in 2015
1.3.2 Prognostic Tool for Survival
1.3.3 Non-Invasive Early Diagnosis of Cancer
1.3.4 Predictors of Disease Evolution and Metastatic Potential
1.3.5 Therapy Guidance and Monitoring/Predictor of Response to Therapy
1.3.6 Drug Development-Selection of Drug Targets
1.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Regions
1.4.1North America Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Taiwan Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.4.7 Row Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (2011-2021)
2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Competition by Manufacturers
2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturing Base Distribution, Sales Area, Product Types
2.5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Competitive Situation and Trends?
2.5.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Concentration Rate
2.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue (Value) by Regions (2011-2016)
3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity and Market Share by Regions (2011-2016)
3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production and Market Share by Regions (2011-2016)
3.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Value) and Market Share by Regions (2011-2016)
3.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Taiwan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.11 Row Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption by Regions (2011-2016)
4.2North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Taiwan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Export, Import by Regions (2011-2016)
4.8 Row Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Revenue (Value), Price Trend by Types
5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production and Market Share by Types (2011-2016)
5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Types (2011-2016)
5.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price by Type (2011-2016)
5.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Growth by Type (2011-2016)
6 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis by Applications
6.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption and Market Share by Applications (2011-2016)
6.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Growth Rate by Applications (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturers Profiles/Analysis
7.1 Janssen Diagnostics
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.1.2.1 Type one
7.1.2.2 Type two
7.1.3 Janssen Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2 QIAGEN Hannover GmbH
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.2.2.1 Type one
7.2.2.2 Type two
7.2.3 QIAGEN Hannover GmbH Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3 Acousys Biodevices, Inc.
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.3.2.1 Type one
7.3.2.2 Type two
7.3.3 Acousys Biodevices, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4 Advanced Cell Diagnostics, Inc.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.4.2.1 Type one
7.4.2.2 Type two
7.4.3 Advanced Cell Diagnostics, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5 ApoCell, Inc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.5.2.1 Type one
7.5.2.2 Type two
7.5.3 ApoCell, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6 BioCEP Ltd.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.6.2.1 Type one
7.6.2.2 Type two
7.6.3 BioCEP Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7 Biocept, Inc.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.7.2.1 Type one
7.7.2.2 Type two
7.7.3 Biocept, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8 Biofluidica
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.8.2.1 Type one
7.8.2.2 Type two
7.8.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9 BioView Ltd.
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.9.2.1 Type one
7.9.2.2 Type two
7.9.3 BioView Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10 Clearbridge Biomedics Pte Ltd.
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types, Application and Specification
7.10.2.1 Type one
7.10.2.2 Type two
7.10.3 Clearbridge Biomedics Pte Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.11 Creatv MicroTech, Inc.
7.12 Cynvenio Biosystems
7.13 CytoTrack ApS
7.14 DeNovo Sciences Inc.
7.15 Epic Sciences
7.16 Fluidigm Corporation
7.17 Fluxion Biosciences
7.18 Miltenyi Biotec GmbH
7.19 SRI Biosystems
7.20 RareCells Diagnostics
8 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturing Cost Analysis
8.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
9 Non-Invasive Early Diagnosis of Cancer Chain, Sourcing Strategy and Downstream Buyers
9.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Non-Invasive Early Diagnosis of Cancer Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast (2016-2021)
12.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue Forecast (2016-2021)
12.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Forecast by Type (2016-2021)
12.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Forecast by Application (2016-2021)
12.5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure Global Production Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Types in 2015
Table Classification of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure Product Picture of Enrichment Methods Based on Physical Properties
Table Major Manufacturers of Enrichment Methods Based on Physical Properties
Figure Product Picture of Immuno-Mediated Capture Methods
Table Major Manufacturers of Immuno-Mediated Capture Methods
Figure Product Picture of Optical Identification and Enumeration
Table Major Manufacturers of Optical Identification and Enumeration
Figure Product Picture of Nucleic Acid-based CTC Detection Methods
Table Major Manufacturers of Nucleic Acid-based CTC Detection Methods
Figure Product Picture of Virus Vectors Fluorescence
Table Major Manufacturers of Virus Vectors Fluorescence
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Market Share by Applications in 2015
Table Applications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure Prognostic Tool for Survival Examples
Figure Non-Invasive Early Diagnosis of Cancer Examples
Figure Predictors of Disease Evolution and Metastatic Potential Examples
Figure Therapy Guidance and Monitoring/Predictor of Response to Therapy Examples
Figure Drug Development-Selection of Drug Targets Examples
FigureNorth America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Taiwan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Row Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) and Growth Rate (2011-2021)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity of Key Manufacturers (2015 and 2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity of Key Manufacturers in 2015
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity of Key Manufacturers in 2016
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production of Key Manufacturers (2015 and 2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Share by Manufacturers (2015 and 2016)
Figure 2015 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Share by Manufacturers
Figure 2016 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Share by Manufacturers
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Manufacturers
Table 2016 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Manufacturers
Table Global Market Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Average Price of Key Manufacturers in 2015
Table Manufacturers Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturing Base Distribution and Sales Area
Table Manufacturers Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Types
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share of Top 3 Manufacturers
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share of Top 5 Manufacturers
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity by Regions (2011-2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity Market Share by Regions (2011-2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity Market Share by Regions
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production by Regions (2011-2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production and Market Share by Regions (2011-2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Market Share by Regions (2011-2016)
Figure 2015 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Market Share by Regions
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Regions (2011-2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Regions (2011-2016)
Table 2015 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Regions
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
TableNorth America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Taiwan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Row Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Market by Regions (2011-2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Market Share by Regions (2011-2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Market Share by Regions
TableNorth America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Import & Export (2011-2016)
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Import & Export (2011-2016)
Table China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Import & Export (2011-2016)
Table Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Import & Export (2011-2016)
Table Taiwan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Import & Export (2011-2016)
Table India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Import & Export (2011-2016)
Table Row Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production, Consumption, Import & Export (2011-2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production by Types (2011-2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Share by Types (2011-2016)
Figure Production Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Types (2011-2016)
Figure 2015 Production Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Types
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Types (2011-2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Types (2011-2016)
Figure Production Revenue Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Types (2011-2016)
Figure 2015 Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Types
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price by Types (2011-2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Growth by Type (2011-2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption by Applications (2011-2016)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Market Share by Applications (2011-2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Market Share by Applications in 2015
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Growth Rate by Applications (2011-2016)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Growth Rate by Applications (2011-2016)
Table Janssen Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Janssen Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table QIAGEN Hannover GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table QIAGEN Hannover GmbH Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure QIAGEN Hannover GmbH Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table Acousys Biodevices, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acousys Biodevices, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Acousys Biodevices, Inc.Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table Advanced Cell Diagnostics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Advanced Cell Diagnostics, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Advanced Cell Diagnostics, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table ApoCell, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ApoCell, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure ApoCell, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table BioCEP Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioCEP Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure BioCEP Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table Biocept, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocept, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Biocept, Inc. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table Biofluidica Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table BioView Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioView Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure BioView Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table Clearbridge Biomedics Pte Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Clearbridge Biomedics Pte Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Clearbridge Biomedics Pte Ltd. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure Manufacturing Process Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Non-Invasive Early Diagnosis of Cancer Chain Analysis
Table Raw Materials Sources of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Manufacturers in 2015
Table Major Buyers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table Distributors/Traders List
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Capacity, Production and Growth Rate Forecast (2016-2021)
Figure Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate Forecast (2016-2021)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Forecast by Regions (2016-2021)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Forecast by Regions (2016-2021)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Forecast by Type (2016-2021)
Table Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes
    Published: 11-Apr-2017        Price: US 2495 Onwards        Pages: 214
    Overview This new report builds on our 2014 Insight Pharma Report, Cancer Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies. In that report, we focused on the major classes of cancer immunotherapy drugs that were then emerging from academic and corporate research: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies. This new report includes an updated discussion of approved and clinical stage agents in......
  • Chemotherapy Induced Nausea and Vomiting (CINV) - Epidemiology Insights - 2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 30
    DelveInsight's "Chemotherapy Induced Nausea and Vomiting (CINV)- Epidemiology Insights-2023" Report provides an overview of the disease, historical and forecasted epidemiological data for the Incident cases of Chemotherapy Induced Nausea and Vomiting (CINV) from 2013-2023 for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. Chemotherapy-induced nausea and vomiting (CINV) are both severe side effects of cancer treatment. CINV is a condition which makes a patient uncomf......
  • Colorectal cancer - Market Insights, Epidemiology and Market Forecast-2023
    Published: 01-Apr-2017        Price: US 4950 Onwards        Pages: 115
    DelveInsight's "Colorectal cancer - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market size of the Colorectal Cancer (CRC) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed cases of Colorectal Cancer (CRC) from 2013-2023. According to DelveInsight, the 7MM Diagnosed cases for Colorectal Cancer are expected to increase,......
  • Non-Hodgkin Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast -2023-7MM
    Published: 01-Apr-2017        Price: US 4950 Onwards        Pages: 87
    DelveInsight's "Non-Hodgkin Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Non-Hodgkin Lymphoma for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the diagnosed cases of Non-Hodgkin Lymphoma from 2012-2023. Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. ......
  • Chemotherapy Induced Nausea and Vomiting (CINV) - Market Insights, Epidemiology and Market Forecast- 2023
    Published: 01-Apr-2017        Price: US 4950 Onwards        Pages: 85
    DelveInsight's "Chemotherapy Induced Nausea and Vomiting (CINV)- Market Insights, Epidemiology and Market Forecast-2023" Report provides an overview of the disease and global market size of the Chemotherapy Induced Nausea and Vomiting (CINV) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the Incident cases of Chemotherapy Induced Nausea and Vomiting (CINV) from 2013-2023. Chemotherapy-induced n......
  • B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 152
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2017, provides an overview of the B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline landscape. B-Cell Chronic Lymphocytic Leukemia is a type of slow growing leukemia that affects developing B-lymphocytes (also known as B-cells). Symptoms ......
  • Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 418
    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline landscape. Hodgkin lymphoma is a cancer that starts in white blood cells called lymphocytes. Symptoms include painless swelling of th......
  • Polycythemia Vera - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 68
    Polycythemia Vera - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycythemia Vera - Pipeline Review, H1 2017, provides an overview of the Polycythemia Vera (Oncology) pipeline landscape. Polycythemia Vera (PV) is a stem cell disorder characterized as a panhyperplastic, malignant and neoplastic marrow disorder. Symptoms include itchiness, headache, dizziness, weakness and excessive ......
  • Osteosarcoma - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 255
    Osteosarcoma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteosarcoma - Pipeline Review, H1 2017, provides an overview of the Osteosarcoma (Oncology) pipeline landscape. Osteosarcoma is the most common cancer of the bone that destroys tissue and weakens the bone. It is developed from immature bone cells that normally form new bone tissue. Symptoms include pain, bone fractures, sw......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs